Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Peterson Katharine sold 101 Acrivon Therapeutics, Inc. shares (Form 4)
Traded Aug 18, 2026 · Filed Aug 20, 2026
On Aug 18, 2026, Peterson Katharine (Chief Accounting Officer) sold 101 Acrivon Therapeutics, Inc. shares at US$2.01 for US$203, leaving 18,033 shares. Filed Aug 20, 2026 (Form 4).
- Sold
- 101 shares
- Price
- US$2.01
- Value
- US$203
- Holding after
- 18,033 shares
- Trading plan
- No
- Role
- Chief Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Common Stock | Sale | 101 | US$2.01 | 18,033 | Direct |
Source
Related
- Acrivon Therapeutics, Inc.
- Peterson Katharine
- Acrivon Therapeutics, Inc. shareholders
- Form 4 · Peterson Katharine · May 20, 2026
- Form 4 · Peterson Katharine · May 18, 2026
- Form 4 · Miller Mary · Oct 7, 2026
- Form 4 · Levin Michaela · Sep 2, 2026
- Form 4 · Blume-Jensen Peter · Aug 27, 2026
- Form 4 · Miller Mary · Aug 20, 2026
- Form 4 · Gamelin Erick · Aug 20, 2026